FDA Inspection 1182191 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Oct 20, 2022 in Dunedin, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 20, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Dunedin, FL (United States)